LUDWIG CANCER RESEARCH

Serial Number 86079418
Registration 4542866
800

Registration Progress

Application Filed
Oct 1, 2013
Under Examination
Approved for Publication
Mar 18, 2014
Published for Opposition
Mar 18, 2014
Registered
Jun 3, 2014

Trademark Image

LUDWIG CANCER RESEARCH

Basic Information

Serial Number
86079418
Registration Number
4542866
Filing Date
October 1, 2013
Registration Date
June 3, 2014
Published for Opposition
March 18, 2014
Renewal Date
June 3, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
800
Status Date
Aug 18, 2024
Registration
Registered
Classes
042

Rights Holder

Ludwig Institute for Cancer Research Ltd

99
Address
32nd Floor
600 Third Avenue
New York, NY 10016

Ownership History

Ludwig Institute for Cancer Research Ltd

Original Applicant
99
New York, NY

Ludwig Institute for Cancer Research Ltd

Owner at Publication
99
New York, NY

Ludwig Institute for Cancer Research Ltd

Original Registrant
99
New York, NY

Legal Representation

Attorney
Nathaniel T. Browand

USPTO Deadlines

Next Deadline
3035 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20140603)
Due Date
June 03, 2034
Grace Period Ends
December 03, 2034

Application History

25 events
Date Code Type Description Documents
Aug 18, 2024 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Aug 18, 2024 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Aug 18, 2024 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Aug 18, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jun 3, 2024 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Jun 3, 2023 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Aug 25, 2020 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Aug 25, 2020 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Aug 25, 2020 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jun 3, 2020 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Jun 3, 2019 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jun 3, 2014 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 18, 2014 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 18, 2014 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 26, 2014 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 13, 2014 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Feb 10, 2014 ALIE A ASSIGNED TO LIE Loading...
Jan 21, 2014 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 21, 2014 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 21, 2014 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 21, 2014 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jan 21, 2014 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 15, 2014 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 7, 2013 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 4, 2013 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Medical research, namely, research relating to the study, treatment, detection and prevention of cancer
First Use Anywhere: Aug 8, 2013
First Use in Commerce: Aug 8, 2013

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CANCER RESEARCH"